Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
03/13/2019 03/14/2019 03/15/2019 03/18/2019 03/19/2019 Date
68.04(c) 67.79(c) 67.75(c) 68.03(c) 69.7(c) Last
3 644 881 2 905 102 7 006 033 2 206 927 2 939 772 Volume
+1.49% -0.37% -0.06% +0.41% +2.45% Change
More quotes
Financials (EUR)
Sales 2019 46 456 M
EBIT 2019 8 459 M
Net income 2019 4 335 M
Debt 2019 36 626 M
Yield 2019 4,28%
Sales 2020 48 130 M
EBIT 2020 9 547 M
Net income 2020 5 312 M
Debt 2020 33 849 M
Yield 2020 4,56%
P/E ratio 2019 15,89
P/E ratio 2020 12,64
EV / Sales2019 2,15x
EV / Sales2020 2,02x
Capitalization 63 442 M
More Financials
Company
Bayer is one of the world's leaders in designing, producing, and marketing pharmaceutical products and high-performance materials. Sales are distributed by product family as follows: - healthcare products (48.1%): pharmaceutical products intended for the prevention and treatment of cardiovascular... 
Sector
Pharmaceuticals
Calendar
04/25Earnings Release
More about the company
Surperformance© ratings of Bayer AG
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER AG
07:42pBAYER : Second U.S. jury finds Bayer's Roundup caused cancer
RE
07:33pBAYER : Jury Finds Bayer's Roundup Weedkiller Caused Man's Cancer--Update
DJ
06:24pBAYER : Jury Finds Bayer's Roundup Weedkiller Caused Man's Cancer--Update
DJ
05:43pBAYER : Jury Finds Bayer's Roundup Weedkiller Caused Man's Cancer
DJ
05:31pBAYER : Jury Finds Bayer's Roundup Weedkiller Caused Man's Cancer
DJ
03/08BAYER : Expiring Patents Add to Bayer Ills
DJ
03/07BAYER : Correction to Second Roundup Weedkiller Trial
DJ
03/07BAYER'S OTHER BIG CHALLENGE : Finding Its Next Blockbuster Drugs
DJ
03/04BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
03/01Macquarie leading bidder for Bayer's chemical park operator - sources
RE
More news
Analyst Recommendations on BAYER AG
More recommendations
Stock Trading Strategies
BAYER - 01/07
The beginning of the move
BUY
More Stock Trading Analysis
Sector news : Pharmaceuticals - NEC
06:03pBRISTOL MYERS SQUIBB : Correction to Bristol-Myers Squibb Overheard Article
DJ
04:59pJOHNSON & JOHNSON : FDA Issues Warning Letters to Two Breast-Implant Manufacture..
DJ
02:29pGLAXO : Tesaro Asset Dostarlimab Showing Positive Results
DJ
02:19pGLAXOSMITHKLINE : GSK reports positive data from trial of endometrial cancer dru..
RE
01:34pJOHNSON & JOHNSON : Oxfam America Files Proxy on J&J Drug Pricing, Executive Com..
DJ
More sector news : Pharmaceuticals - NEC
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 91,0 €
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG12.33%72 005
JOHNSON & JOHNSON6.29%365 252
NOVARTIS10.99%237 519
ROCHE HOLDING LTD.11.34%233 250
PFIZER-4.22%232 121
MERCK AND COMPANY6.47%209 982